Statistical properties of time to first relapse as an endpoint in multiple sclerosis clinical trials

被引：0
|
作者：
Signori, A.
Siri, P.
Sormani, M. P.
机构：
[1] Univ Genoa, Genoa, Italy
[2] Politecn Torino, Turin, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [21] Statistical methods for the analysis of relapse data in MS clinical trials
    Wang, Y. C.
    Meyerson, L.
    Tang, Y. Q.
    Qian, N.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 (1-2) : 206 - 211
  • [22] Statistical methods for relapse data analysis in MS clinical trials
    Wang, Y.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S52 - S52
  • [23] Contribution of age to severity of first multiple sclerosis relapse and short-term clinical outcome
    Gurevich, M.
    Khavkin, Y.
    Menascu, S.
    Achiron, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 597 - 597
  • [24] Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues
    Sankoh, AJ
    D'Agostino, RB
    Huque, MF
    [J]. STATISTICS IN MEDICINE, 2003, 22 (20) : 3133 - 3150
  • [25] An overview of statistical methods for multiple failure time data in clinical trials - Discussion
    Cook, RJ
    Lawless, JF
    [J]. STATISTICS IN MEDICINE, 1997, 16 (08) : 841 - 843
  • [26] MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
    Barkhof, Frederik
    Simon, Jack H.
    Fazekas, Franz
    Rovaris, Marco
    Kappos, Ludwig
    de Stefano, Nicola
    Polman, Chris H.
    Petkau, John
    Radue, Ernst W.
    Sormani, Maria P.
    Li, David K.
    O'Connor, Paul
    Montalban, Xavier
    Miller, David H.
    Filippi, Massimo
    [J]. NATURE REVIEWS NEUROLOGY, 2012, 8 (01) : 13 - 21
  • [27] MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
    Frederik Barkhof
    Jack H. Simon
    Franz Fazekas
    Marco Rovaris
    Ludwig Kappos
    Nicola de Stefano
    Chris H. Polman
    John Petkau
    Ernst W. Radue
    Maria P. Sormani
    David K. Li
    Paul O'Connor
    Xavier Montalban
    David H. Miller
    Massimo Filippi
    [J]. Nature Reviews Neurology, 2012, 8 : 13 - 21
  • [28] Statistical Efficiency of Phase II Multiple Sclerosis Clinical Trials with Different MRI Scanning Frequencies
    Zhao, Y.
    Chen, J.
    Li, D. K. B.
    Riddehough, A.
    Traboulsee, A.
    Petkau, A. J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 680 - 680
  • [29] Lesion load reproducibility and statistical sensitivity of clinical trials in multiple sclerosis - Reply from the authors
    Filippi, M
    Sormani, MP
    Barkhof, F
    van Waesberghe, JH
    Gawne-Cain, ML
    Miller, DH
    Gasperini, C
    Grimaud, J
    [J]. NEUROLOGY, 1999, 52 (02) : 434 - 435
  • [30] Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint
    Healy, Brian C.
    Ikle, David
    Macklin, Eric A.
    Cutter, Gary
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (07) : 840 - 847
12345